Treatment and management of cognitive dysfunction in patients with multiple sclerosis
J DeLuca, ND Chiaravalloti, BM Sandroff - Nature Reviews Neurology, 2020 - nature.com
Cognitive impairment is a common and devastating manifestation of multiple sclerosis (MS).
Although disease-modifying therapies have been efficacious for reducing relapse rates in …
Although disease-modifying therapies have been efficacious for reducing relapse rates in …
Association between pathological and MRI findings in multiple sclerosis
M Filippi, W Brück, D Chard, F Fazekas… - The Lancet …, 2019 - thelancet.com
Pathological evaluation is the gold standard for identifying processes related to multiple
sclerosis that explain disease manifestations, and for guiding the development of new …
sclerosis that explain disease manifestations, and for guiding the development of new …
Structural brain changes in patients with post-COVID fatigue: a prospective observational study
Background Post-COVID syndrome is a severe long-term complication of COVID-19.
Although fatigue and cognitive complaints are the most prominent symptoms, it is unclear …
Although fatigue and cognitive complaints are the most prominent symptoms, it is unclear …
Identifying the distinct cognitive phenotypes in multiple sclerosis
E De Meo, E Portaccio, A Giorgio, L Ruano… - JAMA …, 2021 - jamanetwork.com
Importance Cognitive impairment is a common and disabling feature of multiple sclerosis
(MS), but a precise characterization of cognitive phenotypes in patients with MS is lacking …
(MS), but a precise characterization of cognitive phenotypes in patients with MS is lacking …
Modeling neurodegenerative disorders in zebrafish
AA Bashirzade, KN Zabegalov, AD Volgin… - Neuroscience & …, 2022 - Elsevier
Neurodegeneration is a major cause of Alzheimer's, Parkinson's, Huntington's, multiple and
amyotrophic lateral sclerosis, pontocerebellar hypoplasia, dementia and other related brain …
amyotrophic lateral sclerosis, pontocerebellar hypoplasia, dementia and other related brain …
Deep grey matter injury in multiple sclerosis: a NAIMS consensus statement
Although multiple sclerosis has traditionally been considered a white matter disease,
extensive research documents the presence and importance of grey matter injury including …
extensive research documents the presence and importance of grey matter injury including …
Behavioural phenotypes in the cuprizone model of central nervous system demyelination
The feeding of cuprizone (CPZ) to animals has been extensively used to model the
processes of demyelination and remyelination, with many papers adopting a narrative linked …
processes of demyelination and remyelination, with many papers adopting a narrative linked …
[HTML][HTML] Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis
FR Rizzo, L Guadalupi, K Sanna, V Vanni… - Brain, Behavior, and …, 2021 - Elsevier
Exercise is increasingly recommended as a supportive therapy for people with Multiple
Sclerosis (pwMS). While clinical research has still not disclosed the real benefits of exercise …
Sclerosis (pwMS). While clinical research has still not disclosed the real benefits of exercise …
Complement-associated loss of CA2 inhibitory synapses in the demyelinated hippocampus impairs memory
V Ramaglia, M Dubey, MA Malpede, N Petersen… - Acta …, 2021 - Springer
The complement system is implicated in synapse loss in the MS hippocampus, but the
functional consequences of synapse loss remain poorly understood. Here, in post-mortem …
functional consequences of synapse loss remain poorly understood. Here, in post-mortem …
Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis
RR Voskuhl, A MacKenzie-Graham - Frontiers in Molecular …, 2022 - frontiersin.org
Animal models of multiple sclerosis (MS), specifically experimental autoimmune
encephalomyelitis (EAE), have been used extensively to develop anti-inflammatory …
encephalomyelitis (EAE), have been used extensively to develop anti-inflammatory …